Focused commercial leadership for specialist life sciences firms.
NorthPoint:Bio operates alongside founders and partners to unlock the next phase of growth.
NorthPoint:Bio works across multiple life sciences business models, each with distinct commercial and investment dynamics.
Sectors
Pricing & Market Access Consultancies
Commercial Strategy Consultancies
Due Dilligence & Transaction Advisory
Specialist Life Science Tech Platforms
Launch Strategy AI Platforms
Life Science Investors
When to engage with NorthPoint:Bio
Growth is overly dependent on one or two senior partners.
A new service or offering needs greater momentum in the market.
The pipeline looks busy, but is not well qualified, with insufficient senior-level conversations feeding the top of the funnel.
Senior people are expected to sell, but lack a practical, individual approach to BD, creating frustration and retention risk.
Target accounts have been priorities for years, with progress slower than it should be.
Client relationships and proposals are strong, but ownership and conversion are uneven and not always clearly strategic.
Management is conscious that diligence will examine these areas more closely than clients ever have.
NorthPoint:Bio works alongside leadership teams to sharpen focus and build momentum before these issues surface in diligence or the market.